![Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology](https://www.frontiersin.org/files/Articles/564983/fonc-10-01688-HTML-r1/image_m/fonc-10-01688-g001.jpg)
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology
![Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrd4280/MediaObjects/41573_2014_Article_BFnrd4280_Fig1_HTML.jpg)
Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery
![Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S155041311630362X-fx1.jpg)
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils - ScienceDirect
![Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology](https://www.frontiersin.org/files/Articles/584303/fimmu-11-584303-HTML/image_m/fimmu-11-584303-g001.jpg)
Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology
![Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/f4884eb7-b0aa-4130-800b-72f96a4722c2/7ff1.jpeg)
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
![Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0a7a48b1-ad8f-4b53-834f-839c2b74ef35/gr1_lrg.jpg)
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology
![Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML](https://www.mdpi.com/cancers/cancers-11-00788/article_deploy/html/images/cancers-11-00788-g002.png)
Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML
![The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models - ScienceDirect The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1388198119301970-ga1.jpg)
The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models - ScienceDirect
![Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-021-01720-w/MediaObjects/41388_2021_1720_Fig1_HTML.png)
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene
![Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb7a03ad-b131-4081-8f23-667aadcd228e/gr6_lrg.jpg)
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate | Bioconjugate Chemistry
![Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/e7e7ad5d-68e3-4585-a1d2-861c0f4d29c9/bph15286-fig-0003-m.jpg)
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library
![LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram](https://www.researchgate.net/profile/Thomas-Burris-3/publication/11050323/figure/fig2/AS:486696237178885@1493048833468/LXR-agonist-T0901317-down-regulates-the-hepatic-gluconeogenesis-pathway-in-vivo-Animals_Q640.jpg)
LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram
![Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/2a8825c7-c345-404a-99fb-6a5f3341bcb3/feb212702-fig-0004-m.jpg)
Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library
![LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-56038-1/MediaObjects/41598_2019_56038_Fig1_HTML.png)